Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shalini Ryan

Pediatrics Englewood, OH Doctor of Osteopathy

NPI 1760568984 CMS profile 413494

9000 N Main St Ste 332, Englewood, OH 45415

Open in the dashboard

General payments

$2,667

158 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shalini Ryan of Englewood, OH is reported in the CMS Open Payments database as having received $2,667 across 158 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $103 5
2024 General $912 53
2023 General $468 25
2022 General $455 27
2021 General $283 17
2020 General $249 16
2019 General $196 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shalini Ryan
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Shalini Ryan were reported at $103. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Shalini Ryan Pediatrics median Middle half National median
2019 $196 $86 $31–$183 $163
2020 $249 $49 $22–$110 $114
2021 $283 $68 $27–$158 $132
2022 $455 $77 $30–$173 $149
2023 $468 $88 $33–$190 $160
2024 $912 $94 $34–$206 $164
2025 $103 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Corium, Inc. $500 43 payments
  2. Merck Sharp & Dohme Corporation $434 24 payments
  3. Supernus Pharmaceuticals, Inc. $306 5 payments
  4. GlaxoSmithKline, LLC. $218 15 payments
  5. kaleo, Inc. $206 15 payments
  6. Adlon Therapeutics L.P. $173 10 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $166 10 payments
  8. Ironshore Pharmaceuticals Inc. $157 8 payments
  9. Tris Pharma Inc $87 5 payments
  10. Sanofi Pasteur Inc. $54 3 payments
  11. Other $366 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,667 158 payments
Products named General payments · program years 2019–2025
  1. Azstarys $500 43 payments
  2. GARDASIL 9 $394 21 payments
  3. VAXELIS $319 17 payments
  4. Qelbree $271 3 payments
  5. VAXNEUVANCE $240 13 payments
  6. BEXSERO $218 15 payments
  7. AUVI-Q $206 15 payments
  8. ADHANSIA XR $173 10 payments
  9. VAQTA $113 6 payments
  10. JORNAY PM $109 5 payments
  11. Other $1,266 74 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

158 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record